Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It?
Overcoming the limited bioavailability and extensive metabolism of effective in vitro drugs remains a challenge that limits the translation of promising drugs into clinical trials. Resveratrol, despite its well-reported therapeutic benefits, is not metabolically stable and thus has not been utilized...
Saved in:
Main Authors: | Mohamed Salla (Author), Nadine Karaki (Author), Belal El Kaderi (Author), Abeer J. Ayoub (Author), Samar Younes (Author), Maya N. Abou Chahla (Author), Shairaz Baksh (Author), Sami El Khatib (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of the Encapsulation in Bioavailability of Phenolic Compounds
by: Josipa Grgić, et al.
Published: (2020) -
Derivatization in Analytical Chemistry
Published: (2022) -
Strategies to Improve Resveratrol Systemic and Topical Bioavailability: An Update
by: Sebastiano Intagliata, et al.
Published: (2019) -
Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent
by: Muhammad Ali, et al.
Published: (2024) -
Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper–Lin small composite design
by: El-Say KM
Published: (2016)